Company Overview
Our company was founded in 2013 for the purpose of producing cannabis under Health Canada’s Marihuana for
Medical Purposes Regulations (“MMPR”). We became the 17th licensed producer in Canada in March 2014 and made
our first sale of medical cannabis in May 2015.
The MMPR was replaced by the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) in August 2016.
Under our current ACMPR license, we are authorized to produce and sell cannabis to medical patients in dried and oil
form. Our license has a term ending on October 15, 2019 and we are not currently aware of any circumstances that
would impede renewal.
We cultivate, process and package medical cannabis at our facilities in Gatineau, Québec. Our corporate offices, R&D
and product development are located on the same 143-acre site. We were the first licensed producer in Québec and
are the only publicly traded cannabis company headquartered in Québec.
To date, we have sold over one million grams of medical cannabis to thousands of patients across Canada who count
on us for safe, high quality products. We have acquired valuable experience and knowledge by serving these patients,
while developing an extensive product line and establishing a distinct brand that positions us favourably for the
opening of the adult recreational market.
Investors have responded positively to both our strategy and execution, as evidenced by the $313.0 million we have
raised in public markets since July 2017, making us one of the best-capitalized companies in the industry.
As at April 30, 2018, we employ approximately 137 people. Which included 23 people in cultivation and harvesting;
38 in operations, manufacturing and processing; 40 in sales and marketing; 6 in quality assurance and research and
development, and 30 in corporate services and executive.
Management Discussion & Analysis
For the three- and nine-month periods ended April 30, 2018
(In thousands of Canadian dollars, except share and
per share amounts, and where otherwise noted)
We do not, and do not intend to, carry on business, directly or indirectly, in any business that derives revenue, directly
or indirectly, from the sale of cannabis or cannabis products in the United States or in any other jurisdiction where the
sale of cannabis is unlawful under applicable laws.
For additional information about our corporate structure, please refer to our Annual Information Form for the fiscal
year ended July 31, 2017, which is available under our profile on SEDAR at www.sedar.com.
